Item Details

Print View

The Fungal Meningitis Outbreak: Could It Have Been Prevented? : Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, Second Session, November 14, 2012

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Format
EBook; Book; Government Document; Online
Published
Washington : U.S. Government Printing Office, 2014.
Language
English
SuDoc Number
Y 4.C 73/8:112-181
Description
1 online resource (iii, 293 pages) : illustration
Notes
  • Title from title screen (viewed on Aug. 22, 2014).
  • Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
  • "Serial No. 112-181."
  • Includes bibliographical references.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 02515cam a2200505 i 4500
    001 u6426195
    003 SIRSI
    005 20141215120312.0
    006 m o d f
    007 cr bn||||a||||
    008 140822s2014 dcua ob f000 0 eng c
    035
      
      
    a| (OCoLC)888406343
    042
      
      
    a| pcc
    043
      
      
    a| n-us---
    040
      
      
    a| GPO b| eng e| rda e| pn c| GPO d| GPO d| COO d| OCLCO d| GPO d| MvI
    049
      
      
    a| VA@@
    050
    1
    4
    a| KF27 b| .E5546 2014j
    074
      
      
    a| 1019-C-01 (online)
    088
      
      
    a| Serial no. 112-181 (United States. Congress. House. Committee on Energy and Commerce)
    086
    0
      
    a| Y 4.C 73/8:112-181
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Oversight and Investigations, e| author.
    245
    1
    4
    a| The fungal meningitis outbreak : b| could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012.
    264
      
    1
    a| Washington : b| U.S. Government Printing Office, c| 2014.
    300
      
      
    a| 1 online resource (iii, 293 pages) : b| illustration
    336
      
      
    a| text b| txt 2| rdacontent
    337
      
      
    a| computer b| c 2| rdamedia
    338
      
      
    a| online resource b| cr 2| rdacarrier
    500
      
      
    a| Title from title screen (viewed on Aug. 22, 2014).
    500
      
      
    a| Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
    504
      
      
    a| Includes bibliographical references.
    500
      
      
    a| "Serial No. 112-181."
    650
      
    0
    a| Meningitis z| United States x| Prevention.
    650
      
    0
    a| Drugs x| Dosage forms x| Health aspects z| United States.
    650
      
    0
    a| Drug factories x| Inspection z| United States.
    650
      
    0
    a| Pharmaceutical industry x| Government policy z| United States.
    655
      
    7
    a| Legislative hearings. 2| lcgft
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. t| Fungal meningitis outbreak w| (DLC) 2014406659 w| (OCoLC)889238489
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. t| Fungal meningitis outbreak w| (OCoLC)896878622
    856
    4
    0
    u| http://purl.fdlp.gov/GPO/gpo51505
    596
      
      
    a| 1
    999
      
      
    a| Y 4.C 73/8:112-181 w| SUDOC i| 6426195-1001 l| INTERNET m| UVA-LIB t| INTERNET
▾See more
▴See less

Availability

Google Preview

Google Books Preview

Read Online